156 related articles for article (PubMed ID: 31039932)
1. Improving gout education from patients' perspectives: a focus group study of Māori and Pākehā people with gout.
Rolston CJ; Conner TS; Stamp LK; Neha T; Pitama S; Fanning N; Janes R; Judd A; Hudson B; Hegarty RM; Treharne GJ
J Prim Health Care; 2018 Oct; 10(3):194-200. PubMed ID: 31039932
[TBL] [Abstract][Full Text] [Related]
2. Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach.
Lawrence A; Scott S; Saparelli F; Greville G; Miller A; Taylor A; Gow P
J Prim Health Care; 2019 Jul; 11(2):117-127. PubMed ID: 32171354
[TBL] [Abstract][Full Text] [Related]
3. Maori experiences and perceptions of gout and its treatment: a kaupapa Maori qualitative study.
Te Karu L; Bryant L; Elley CR
J Prim Health Care; 2013 Sep; 5(3):214-22. PubMed ID: 23998172
[TBL] [Abstract][Full Text] [Related]
4. Education Preferences of People With Gout: Exploring Differences Between Indigenous and Nonindigenous Peoples from Rural and Urban Locations.
Treharne GJ; Richardson AC; Neha T; Fanning N; Janes R; Hudson B; Judd A; Pitama S; Stamp LK
Arthritis Care Res (Hoboken); 2018 Feb; 70(2):260-267. PubMed ID: 28464485
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol use in a New Zealand population: prevalence and adherence.
Horsburgh S; Norris P; Becket G; Arroll B; Crampton P; Cumming J; Keown S; Herbison P
Rheumatol Int; 2014 Jul; 34(7):963-70. PubMed ID: 24390636
[TBL] [Abstract][Full Text] [Related]
6. National prevalence of gout derived from administrative health data in Aotearoa New Zealand.
Winnard D; Wright C; Taylor WJ; Jackson G; Te Karu L; Gow PJ; Arroll B; Thornley S; Gribben B; Dalbeth N
Rheumatology (Oxford); 2012 May; 51(5):901-9. PubMed ID: 22253023
[TBL] [Abstract][Full Text] [Related]
7. An enquiry into the crippling gout affecting Pacific Islander and Māori men in Western Sydney.
Coleman W; Spencer D; Wong P; Manolios N
Int J Rheum Dis; 2021 Nov; 24(11):1394-1401. PubMed ID: 34611996
[TBL] [Abstract][Full Text] [Related]
8. Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study.
Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; McLachlan AJ; Day RO
BMC Fam Pract; 2018 May; 19(1):54. PubMed ID: 29743018
[TBL] [Abstract][Full Text] [Related]
9. The inequity of access to health: a case study of patients with gout in one general practice.
Karu LT; Harwood M; Arroll B; Bryant L; Kenealy T
N Z Med J; 2021 Oct; 134(1543):51-58. PubMed ID: 34695076
[TBL] [Abstract][Full Text] [Related]
10. The experience and impact of gout in Māori and Pacific people: a prospective observational study.
Dalbeth N; House ME; Horne A; Te Karu L; Petrie KJ; McQueen FM; Taylor WJ
Clin Rheumatol; 2013 Feb; 32(2):247-51. PubMed ID: 23114632
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricaemia and gout in New Zealand rural and urban Māori and non-Māori communities.
Stamp LK; Wells JE; Pitama S; Faatoese A; Doughty RN; Whalley G; Richards AM; Cameron VA
Intern Med J; 2013 Jun; 43(6):678-84. PubMed ID: 23279108
[TBL] [Abstract][Full Text] [Related]
12. A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout.
Richardson JC; Liddle J; Mallen CD; Roddy E; Hider S; Prinjha S; Ziebland S
BMC Musculoskelet Disord; 2016 Jun; 17():249. PubMed ID: 27267878
[TBL] [Abstract][Full Text] [Related]
13. Ethnic differences in diabetes knowledge and education: the South Auckland Diabetes Survey.
Simmons D; Shaw L; Kenealy T; Scott D; Scragg R
N Z Med J; 1994 May; 107(978):197-200. PubMed ID: 8196864
[TBL] [Abstract][Full Text] [Related]
14. Patient awareness, knowledge and use of colchicine: an exploratory qualitative study in the Counties Manukau region, Auckland, New Zealand.
Rebello C; Thomson M; Bassett-Clarke D; Martini N
J Prim Health Care; 2016 Jun; 8(2):140-8. PubMed ID: 27477556
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand.
Gosling AL; Boocock J; Dalbeth N; Harré Hindmarsh J; Stamp LK; Stahl EA; Choi HK; Matisoo-Smith EA; Merriman TR
Ann Rheum Dis; 2018 Apr; 77(4):571-578. PubMed ID: 29247128
[TBL] [Abstract][Full Text] [Related]
16. "It's complicated" - talking about gout medicines in primary care consultations: a qualitative study.
Morris C; Macdonald L; Stubbe M; Dowell A
BMC Fam Pract; 2016 Aug; 17(1):114. PubMed ID: 27542754
[TBL] [Abstract][Full Text] [Related]
17. How Can We Improve Disease Education in People with Gout?
Fields TR; Batterman A
Curr Rheumatol Rep; 2018 Mar; 20(3):12. PubMed ID: 29516200
[TBL] [Abstract][Full Text] [Related]
18. Ngā Whakāwhitinga (standing at the crossroads): How Māori understand what Western psychiatry calls "schizophrenia".
Taitimu M; Read J; McIntosh T
Transcult Psychiatry; 2018 Apr; 55(2):153-177. PubMed ID: 29455628
[TBL] [Abstract][Full Text] [Related]
19. A qualitative study to explore health professionals' experience of treating gout: understanding perceived barriers to effective gout management.
Humphrey C; Hulme R; Dalbeth N; Gow P; Arroll B; Lindsay K
J Prim Health Care; 2016 Jun; 8(2):149-56. PubMed ID: 27477557
[TBL] [Abstract][Full Text] [Related]
20. Variation in gout care in Aotearoa New Zealand: a national analysis of quality markers.
Jackson G; Dalbeth N; Te Karu L; Winnard D; Gow P; Gerard C; Minko N
N Z Med J; 2014 Oct; 127(1404):37-47. PubMed ID: 25331310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
